MolBreeding

About MolBreeding

Shijiazhuang Boredy Biotechnology, operating under the brand Molbreeding, is a biotechnology firm established in 2017 with a focus on molecular breeding technology for the agricultural and animal science sectors. The company was founded by Jianan Zhang and is headquartered in Shijiazhuang, China. It has secured significant funding, raising a total of $79.4 million, including a recent Series B round of $34.4 million on July 30, 2024, with notable investors such as Alibaba Group, Gaw Capital Partners, and CITIC PE.

Molbreeding provides high-throughput genotyping solutions designed to accelerate and optimize breeding programs. The company's core business revolves around its proprietary Genotyping by Targeted Sequencing (GBTS) technology, which aims to deliver high precision and scalability at a reduced cost. Its client base includes researchers and breeding teams in academia, government, and various industries, spanning crops, livestock, aquaculture, and even pets. Revenue is generated through genotyping services and the sale of related products.

The firm offers a comprehensive suite of products and services. This includes end-to-end genotyping services, from DNA extraction and library construction to bioinformatics data analysis. A key product is its offering of ready-to-use and custom GBTS marker panels, such as GenoPlexs® (multi-plex PCR) and GenoBaits® (probe hybridization), for over 180 species including maize, wheat, cattle, and pigs. Additionally, Molbreeding supplies a range of reagents, software systems for data management and analysis (MIMS, MBAP), and automated laboratory instruments to support in-house testing by its clients.